000 a
999 _c15693
_d15693
003 OSt
005 20211222131151.0
008 211222b xxu||||| |||| 00| 0 eng d
040 _aAIKTC-KRRC
_cAIKTC-KRRC
100 _914972
_aKarumanchi, Srikanth Kumar
245 _aDesign, Synthesis, Hypoglycemic Activity and Molecular Docking Studies of 3-substituted-5- [(furan-2-yl)-methylene]-thiazolidine-2,4-dione Derivatives
250 _aVol.55(1), Jan-Mar
260 _aKarnataka
_bAssociation of Pharmaceutical Teachers of India (APTI)
_c2021
300 _a266-275p.
520 _aBackground: From the wide range of previous literature studies indicated that thiazolidinedione’s reacts with substituted benzaldehydes undergoes knoevenagel condensation gives respective arylidene derivatives. In our attempt all the titled compounds were designed and developed by replacement of substituted benzaldehydes with furan- 2-aldehyde, so that furan moiety was introduced in the molecule. Materials and Methods: 5-[(furan-2-yl)-methylene]-thiazolidine-2,4-dione was prepared via knoevenagel condensation by the reaction of thiazolidine-2,4-dione and furfural. Further it was coupled with various alkyl/ aryl halides in alcoholic potassium hydroxide to produce various derivatives 2a-2j. The titled compounds furthermore prepared by microwave assisted synthesis technique. Synthesized compounds were analysed by physical and spectral characterization methods. Developed furan bearing thiazolidine-2,4-diones were evaluated for in-vivo hypoglycemic property. Molecular docking analysis was carried out to observe the binding interaction of designed ligands at PPARγ target receptor protein. Results and Conclusion: Microwave irradiation technique produced high yield at less reaction time in comparison with traditional conventional method. In-vivo hypoglycemic activity evaluation revealed that, electron releasing groups (-OH and –OCH3) containing compounds 2d and 2g found to possess significant activity in acute study as well as in chronic study. Even the molecular docking studies at PPARγ receptor protein (PDB ID- 2PRG), electron releasing groups containing compounds 2d and 2g exhibit significant binding affinity having high binding energy of -9.02 kcal/mol and -8.61 kcal/mol when compared with standard ligand rosiglitazone.
650 0 _94639
_aPHARMACEUTICS
700 _914973
_a Rao, Atmakuri Lakshmana
773 0 _dBengluru Association of Pharmaceutical Teachers of India (APTI)
_x0019-5464
_tIndian journal of pharmaceutical education and research
856 _uhttps://www.ijper.org/sites/default/files/IndJPhaEdRes_55_1_266.pdf
_yClick here
942 _2ddc
_cAR